We plan to begin the subject review in October 2018. We will perform this review in accordance with the Office of National Drug Control Policy Circular, “Accounting of Drug Control Funding and Performance Summary,” May 8, 2018. The Circular requires the DoD to provide a performance summary report to the Director, Office of National Drug Control Policy. The objective of the review is to attest to whether the FY 2018 DoD Performance Summary Report is presented, in all material respects, in accordance with the Circular. We will conduct sufficient work to express a conclusion and provide limited assurance regarding the presentation of the FY 2018 DoD Performance Summary Report. To provide limited assurance, the procedures we perform will be generally limited to inquiries and analytical procedures.